S&P 500 7,676.77 +0.70%
Nasdaq 26,169.38 +0.82%
S&P/TSX 35,944.16 +0.44%
Apple 343.91 −1.10%
Nvidia 216.00 +2.39%
Microsoft 532.60 +1.54%
Shopify 235.93 −0.13%
Royal Bank 284.26 +0.88%
CAD/USD 0.7134 −0.03%
CLOSED · 03:45 ET
Market ClerkRecap
Tue Oct 27 · markets closed1 signal on Oct 26140 insider buys this week · $73.9MCIRO short report next: Oct 30The week ahead

FATE

FATE THERAPEUTICS INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
2.06
−0.05 −2.37%
USD · close Oct 26

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $246.8MP/E —DIV YIELD —FCF YIELD -42.79%REV TTM $6.5M −23.4%NET INCOME −$126MNET CASH $13.9M52W 0.96 – 3.11SEC XBRL · TTM TO Invalid Date

What FATE had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
FiledWhat was reportedEvent dateDocument
Sep 28Other eventSep 25open on EDGAR ↗

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch FATE. Know when insiders buy.
One email the day a filing lands. Free.